Maria L. Carcangiu
Via Amadeo 42
Milan, 20133, Italy
Milan, 20133, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Malignant salivary gland tumours in families with breast cancer susceptibility.
Journal: Virchows Archiv : an international journal of pathology
Published: December 26, 2019
Corrigendum to ``Survey of gynecological carcinosarcomas in families with breast and ovarian cancer predisposition'' [Cancer Genet. 221(2018) 38-45].
Journal: Cancer genetics
Published: December 18, 2018
Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy?
Journal: Breast (Edinburgh, Scotland)
Published: May 25, 2018
Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 22, 2018
HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy.
Journal: Oncoimmunology
Published: March 15, 2018
Neoadjuvant Chemotherapy Exerts Selection Pressure Towards Luminal Phenotype Breast Cancer.
Journal: Breast care (Basel, Switzerland)
Published: February 20, 2018
Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients.
Journal: Endocrine-related cancer
Published: December 27, 2017
Survey of gynecological carcinosarcomas in families with breast and ovarian cancer predisposition.
Journal: Cancer genetics
Published: August 07, 2017
Regarding "The Role of Routine Peritoneal and Omental Biopsies at Risk-reducing Salpingo-oophorectomy".
Journal: Journal of minimally invasive gynecology
Published: May 25, 2017
Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective study.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: April 15, 2017
Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience.
Journal: Journal of minimally invasive gynecology
Published: April 01, 2017
Last Updated: 09/26/2026